Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Source: SeekingAlpha
2025-12-31 08:22:18 ET
More on Pfizer, GSK, etc.
- Pfizer: Adjusted EPS Masks How Bad 2026 Really Looks
- Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade)
- Pfizer: Downgrade To 'Hold' On Lower 2026 Revenue Guidance And Potential Growth Tracks
- Vanda surges on FDA approval of Lilly-partnered motion sickness therapy
- SA analyst upgrades/downgrades: PLTR, TGT, NET, PFE
Read the full article on Seeking Alpha
For further details see:
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Novartis AG
NASDAQ: NVS
NVS Trading
-0.95% G/L:
$143.97 Last:
434,468 Volume:
$144.01 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
